Cleveland, United States
Centerline Biomedical, founded in 2014 in the United States, is an innovative player in the Biotechnology and Health Care industries. The company has carved a niche with its groundbreaking Intra-Operative Positioning System (IOPS™), a technology transforming surgical navigation by alleviating common issues associated with traditional x-ray fluoroscopy.
By offering a GPS-like 3D vascular navigation system, Centerline Biomedical enables higher accuracy and control in minimally invasive procedures, while significantly reducing radiation exposure risks. Originating as a spinoff from the Cleveland Clinic, the company's solution integrates seamlessly into existing medical workflows, offering a robust alternative to conventional methodologies.
The company attracted a $33.00M Series B investment on 27 June 2022, with backing from prominent investors including JobsOhio, Cleveland Clinic, GE Healthcare, and others. This infusion of capital underscores confidence in their potential to revolutionize healthcare delivery and training.
Stereotaxis
